Thrombospondin (TSP), a multifunctional alpha-granule glycoprotein of platelets, binds fibrinogen, fibronectin, heparin, and histidine-rich glycoprotein and thus may play an important role in regulating thrombotic influences at vessel surfaces. In this study we have demonstrated that purified human platelet TSP formed a complex with purified human plasminogen (Plg). Complex formation was detected by rocket immunoelectrophoresis of mixtures of the purified radiolabeled proteins. Significant complex formation of fluid-phase Plg with adsorbed TSP was also demonstrated by enzyme-linked immunosorbent assay (ELISA). The complex formation was specific, saturable, and inhibited by excess fluidphase TSP, with an apparent KD of approximately 35 nM. In both ELISA and rocket immunoelectrophoresis systems, complex formation was inhibited by 10 mM epsilon-aminon-caproic acid, implying that there is a role for the lysine binding sites of Plg in mediating the interaction. TSP also formed a complex with plasmin as detected by ELISA but did not directly inhibit plasmin activity measured with a synthetic fluorometric substrate or with a 125I-fibrin plate assay. TSP, when incubated with Plg before addition to 125I-fibrin plates significantly inhibited the generation of plasmin activity by tissue plasminogen activator (TPA) in a manner that was calcium dependent. A kinetic study of Plg activation by TPA in the presence of TSP demonstrated that Michaelis-Menten kinetics were followed and that TSP acted as a noncompetitive inhibitor. 
Introduction
Thrombospondin (TSP),' a 450-kD filamentous multinodular glycoprotein (1, 2) consisting of three 140-kD subunits (3), is a major a-granule protein of human platelets (4, 5) and is expressed on the platelet surface upon thrombin stimulation (6) . Although circulating plasma levels are low (20-300 ng/ ml) (7, 8) , human fibroblasts and endothelial cells can release large amounts into their microenvironments (9, 10) . TSP has also been identified as a synthetic product of human monocytes (1 1).
TSP appears to be a molecule of remarkable functional diversity. It may be important in mediating cell-to-cell communication. It is the endogenous lectin of stimulated platelets (12, 13) . TSP binds fibrinogen (14) , and monospecific anti-TSP Fab' partially inhibits both platelet aggregation and platelet fibrinogen binding (15) . TSP also binds collagen and fibronectin (14, 16) and is incorporated into the extracellular matrix of fibroblasts in culture (10) . TSP may play an important role in the coagulation and fibrinolytic systems, as evidenced by its ability to form complexes with histidine-rich glycoprotein (HRGP) (17) , an 80-kD plasma protein with high affinity for heparin (18) , and the lysine binding sites (LBS) of plasminogen (19) .
The TSP-HRGP complex in a focal area ofactive hemostasis and thrombosis such as the vicinity of the platelet membrane could augment thrombotic influences, leading to increased I. Abbreviations used in this paper: AFC, 7 amino-4-trifluoromethyl coumarin; EACA, e-amino-n-caproic acid; ELISA, enzyme-linked immunosorbent assay; HRGP, histidine-rich glycoprotein; I50, 50% inhibitory concentration; kmt,, catalytic rate constant; LBS, lysine binding sites; Plg, plasminogen; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; TPA, tissue plasminogen activator; TSP, thrombospondin; VIIIR:Ag, Factor VIII-related antigen. deposition of fibrin. To define further the participation of TSP in fibrinolysis, the interaction of TSP with plasminogen (Plg) was studied. In this paper we report that TSP forms a specific complex with plasminogen and modulates its activation to plasmin by tissue plasminogen activator (TPA).
Methods
Materials. Microtitration plates for enzyme-linked immunosorbent assays (ELISA) and Linbro tissue culture plates (area, 2.0 cm2; capacity, 3.5 ml) for fibrin plate studies were purchased from Flow Laboratories Inc. (McLean, VA). Electrophoresis grade agarose (Seakem) was purchased from FMC Corp. (Rockland, ME). A fluorometric plasmin substrate, D-val-leu-lys-7 amino-4-trifluoromethyl coumarin (AFC) was purchased from Enzyme Systems Products (Livermore, CA). E-Aminon-caproic acid (EACA) was purchased from Calbiochem-Behring Corp.
(La Jolla, CA). Type VII calf mucosal alkaline phosphatase, p-nitrophenyl phosphate, and soybean trypsin inhibitor were purchased from Sigma Chemical Co. (St. Louis, MO). All reagents were of analytical grade.
Purified proteins. Purified human TSP was prepared as described previously (17) by a modification of the method of Lawler et al. (1) . 4 to 8 U of fresh human platelets were washed and the TSP was isolated from the thrombin-stimulated releasate by Sepharose 4B gel exclusion chromatography followed by heparin Sepharose affinity chromatography. The TSP was 95% pure by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (17) . Purified human glu-Plg was isolated by lysine affinity chromatography (20) followed by gel filtration and was determined to be free of HRGP and fibrinogen by an ELISA specific for these proteins. For the fibrin plate studies, purified human plasminogen (IMCO, Stockholm) was purchased from Mico, USA, New York and was free of TPA activity as determined by the 1251. fibrin plate assay. This preparation was >95% pure by SDS-PAGE and consisted of only the glu form of Plg. Authentic glu and lys Plg were kindly supplied by Dr. F. J. Castellino (University of Notre Dame, IN) and were used as standards for the SDS-PAGE. Purified human plasmin was obtained by activation of purified Plg with insolubilized urokinase, as described previously (21) , and stored at -700C in 50% glycerol. Antithrombin III, albumin, gamma-globulin, Factor VIIIrelated antigen (VIIIR:Ag), a2-plasmin inhibitor, platelet glycoproteins IIb and IlIa, complement components (Ciq, C3, C4, C5), high molecular weight kininogen, coagulation Factors X and XII, and fibronectin, which were used as control proteins for the ELISA and fibrin plate studies, were obtained and purified as described in detail previously (14, 17) . Plg-free human fibrinogen was obtained from IMCO, purified bovine fibrinogen from Calbiochem-Behring Corp. Human melanoma cell line TPA (70,000 IU/mg) was a generous gift of Dr. Desire Collen, University of Leuven, Belgium.
Antisera. Antisera to purified Plg and TSP were raised in rabbits by standard techniques (22) . Anti-Plg did not react as determined by ELISA with purified human fibrinogen, IgG, albumin, fibronectin, TSP, or Factor VIIIR:Ag. Preparation and monospecificity of other antisera has been documented in detail previously (14, 17) . Anti and mixed with the indicated volume of prewarmed antiserum. 3 to 5 ml of antibody-agarose mixture was layered onto glass microscope slides. Antigen samples were applied into 4-mm diam wells and the individual slides were subjected to 50 V and 3 mA for 20 h at 220C.
After electrophoresis the slides were washed exhaustively with saline containing 0.1% azide and followed by a 30-min distilled-water wash, dried, and stained with 1% amido black in 40% ethanol-l0% acetic acid and destained in 90% methanol-5% acetic acid.
Fibrin-agar indicator gels. The fibrin-agar indicator gels were prepared by the method of Reich (24) with the following solutions: (a) 2.5% agar in water boiled for 10 min before use and kept at 450C; (b) phosphate-buffered saline (PBS) supplemented with thrombin (0.2 U/ml) and TPA (0.2 U/ml); and (c) PBS with Plg-free fibrinogen (10 mg/ml). Solution a (3.2 ml) was added to solutions b (1.9 ml) and c (1.3 ml), and the mixture was transferred to prewarmed templates to form a gel free of bubbles. Gels for rocket immunoelectrophoreses were prepared as described above, placed carefully on top of the indicator gel, and sealed in plastic wrap for 18 h in a humid chamber at 37°C. Lysis zones were identified as clear areas in the cloudy background of the unlysed fibrin. The upper immunoelectrophoresis gel was removed and the underlying fibrin layer was stained for 10 min with 0.5% amido black in 40% ethanol-10% acetic acid and destained in 90% methanol-5% acetic acid. The upper gel layer was also stained to determine the completeness of the transfer of the Pigcontaining immunoprecipitate.
ELISA. The assay was performed according to the method of Voller et al. (25) as previously described (14, 17 Digestion of '25I-fibrin films by plasmin or by Pig activated with TPA. Purified human plasmin (0.1 to 1.0 nM) in 200 Ml Tris-saline buffer (20 mM Tris-HCI, 0.15 M NaCl, pH 7.4) containing 0.25% gelatin and 0.006% Tween 80 was added in duplicate to wells of`25I-fibrin coated plates. These were gently rocked at 370C and aliquots were removed at specific time intervals and counted to quantify cumulative release of '25l-fibrin degradation products.
Purified human Plg (100 to 800 nM) in 190 Ml Tris-saline buffer containing 0.25% gelatin, 0.006% Tween 80, and 2.0 mM CaCl2 was added in duplicate to wells of 251I-fibrin coated plates, which were gently rocked at 370C. 10 Ml of TPA (final concentration, 0.24 U/ml) was then added to the wells and 10-Ml aliquots were taken at intervals and counted.
The influence of TSP on the above reaction(s) was studied by incubating Plg or plasmin in buffer as above with TSP (0-200 nM) for I h at room temperature before addition to the 251I-fibrin coated wells.
Control studies substituted Factor VIIIR:Ag or fibronectin at 200 nM for TSP.
Kinetics ofPig activation by TPA in the presence of TSP. Plg (125 to 800 nM) was incubated with TSP (0 to 150 nM) for I h at room temperature in Tris-saline buffer containing 0.25% gelatin, 0.006% Tween 80, and 1.5 mM CaC12 before addition to the wells of 125i-fibrin plates. The Plg was activated with TPA (0.24 U/ml) for 30 min at 37°C and followed by the addition of 10 Ml EACA (final concentration, 80 MM) to terminate the Plg activation. This interval was selected because Hoylaerts et al. (27), using a similar assay, have shown that activation is complete by 20 to 30 min. Our preliminary studies (data not shown) demonstrated >80% activation at 30 min, with no inhibition of activity of formed plasmin by this concentration of EACA. The cumulative solubilization of fibrin by the generated plasmin was measured as described above and the initial reaction rate was calculated as the amount of plasmin generated per second. All studies were done in duplicate.
Results

Demonstration of TSP-Pig complex formation by rocket immunoelectrophoresis
Radiolabeled Plg mixed with TSP (molar ratio 3:1) and electrophoresed into anti-Plg-containing agar migrated more rapidly than Plg alone and formed an anodally moving sharp peak, which contained Plg as detected by immunoprecipitation with monospecific antibody and by autoradiography (Fig. 1, A  and B ). To demonstrate that the anodal moving peak contained TSP complexed to the Plg, studies were performed using 125I-TSP and unlabeled Plg. The fast moving Pig-containing peak demonstrable in antibody agar was radioactive (Fig. 2, A (Fig. 3) . The protease inhibitor was necessary to prevent proteolytic removal of TSP from the plastic plates by plasmin, since it has been shown that TSP is a substrate of plasmin (28) .
Further specificity of complex formation was demonstrated by the inability of fluid-phase Plg to bind other adsorbed proteins. No complex formation was detected with fibronectin, antithrombin III, or Factor VIIIR:Ag (Table I ). These proteins were adequately adsorbed to the plastic wells, as shown by binding of monospecific alkaline phosphatase-conjugated IgG and by '25I-protein A binding studies (14) . We AT-Ill, antithrombin III.
* Proteins (4 gg/ml) in coating buffer were applied to plastic wells for 18 h at 4VC. After washing, Plg (4 gg/ml) was added and binding was determined as described in Fig. 3 .
TSP-Plg complex formation. Incorporation of 10 mM EACA into the anti-Plg antibody agar blocked formation of the rapidly moving anodal peak shown to contain the TSP-Plg complex (Fig. 4) Influence of TSP on the kinetics ofPlg activation by TPA The kinetic analysis of Pig activation by TPA on '251I-fibrin plates was determined by measuring the amount of plasmin generated from a 30-min activation of Pig by TPA (0.24 U/ ml) as determined from S50 values and a plasmin standard curve. Activation followed Michaelis-Menten kinetics with an apparent Km of 0.10 AM and a catalytic rate constant, ksca of 7.6 s-' X 103 (Table III) . The influence of TSP on this reaction was studied and linear plots of i/v vs. 1/Pig were obtained for each TSP concentration using a least squares linear regression analysis (Fig. 8) . These lines show a progressive increase in vertical intercept (l/Vmax) as TSP was increased, with only a corresponding small shift in the horizontal intercept (l/Km), consistent with mixed type inhibition. Although the major component of inhibition was noncompetitive (decrease in Vmax), there may also be a small competitive effect. The second-order rate constants kcatIKm, a measure of the overall catalytic efficiency of Plg activation by TPA, showed that the overall reaction was markedly slowed in the presence of TSP.
TSP influence on plasmin activity Using a synthetic tripeptide fluorometric plasmin substrate (Dval-leu-lys-AFC) it was found that TSP did not inhibit plasmin activity in vitro. No difference in substrate hydrolysis as measured in relative fluorometric units was seen when 6.4 ng/ ml plasmin was mixed with buffer alone or with 1:1, 49:1, or 98:1 molar ratios of TSP/plasmin. Incubation of TSP and plasmin for 30 min before addition of the substrate also had no effect. Similarly, no inhibition of plasmin activity was seen on a '251-fibrin plate assay. No difference in the rate of solubilization of the fibrin was demonstrated when plasmin was incubated with buffer alone or with up to a 500-fold molar excess of TSP before addition to the fibrin plate.
Discussion
TSP, a multifunctional a-granule protein of human platelets (4, 5) , has also been identified in human endothelial cells (7), fibroblasts (10), aortic smooth muscle cells (9) , monocytes (I1), and the extracellular matrix (10). Specific interactions have been identified with heparin (18) , fibrinogen (14) , fibronectin, collagen (16) , and HRGP (17) . These interactions suggest multiple functional roles, for example, in modulating cell-cell communication (12) , cell-substratum interactions, platelet aggregation (15) , and regulation of thrombotic influences at vessel surfaces.
Plg, the circulating zymogen of the serine protease plasmin, is the major enzyme of the fibrinolytic system (29) and in addition may be important in effecting other proteolytic pro-cesses such as inflammation and tumor cell invasion and migration (24, 30) . In this study we have demonstrated by two independent lines of evidence that purified platelet TSP formed a complex with human Plg. By rocket immunoelectrophoresis it was demonstrated that Plg mixed with TSP when electrophoresed into antibody agar moved more rapidly than Plg alone and formed an anodally moving sharp peak which contained Plg as well as TSP (Figs. 1 and 2 ). In addition, an ELISA binding assay, which we have previously used to demonstrate specific TSP interaction with fibrinogen and HRGP (14, 17) , showed specific and saturable binding of Plg to TSP adsorbed on microtitration plates, with an apparent KD of 35 nM (Fig. 3) .
The binding of Plg and TSP is mediated by the LBS of Plg. Saturation of these sites with 10 mM EACA or lysine completely inhibited complex formation in both ELISA and rocket immunoelectrophoresis systems. The 150 of EACA in the competitive inhibition study of -200 gM (Table II) is most consistent with involvement of the high affinity LBS. The protease plasmin that contains the LBS on its A-chain also specifically complexed with TSP (Fig. 3) . The active site of the enzyme was apparently not involved in the complex formation, as incubation with soybean trypsin inhibitor did not prevent binding (Fig. 3) .
The LBS of Plg are critically important in regulating Plg activation (31, 32) , and in mediating the interaction of plasmin(ogen) with fibrin(ogen) and a2-plasmin inhibitor, as well as with HRGP and the antifibrinolytic amino acids. The kinetics of conversion of Plg to plasmin by TPA are highly unfavorable in the fluid phase. However, during blood coagulation both TPA and Plg bind to fibrin, changing the conformation of the proteins so that rapid activation ensues (27) . Since the LBS of Plg appear to mediate complex formation with TSP and since TSP is likely to be present at significant concentrations in the local environment of a clot (via platelet activation and secretion), we have studied the effect of TSP on Plg activation by TPA. A fibrin-agar indicator gel system demonstrated less lysis by the TSP-Plg complex than by equal amounts of Plg alone (Fig. 5) , suggesting that the TSP-Plg complex may be a less efficient substrate for TPA than is pure Plg. That this inhibition of lysis was not due to an anti-plasmin effect of TSP was shown by failure of TSP to inhibit plasmin activity both on a 251I-fibrin plate assay or in fluid phase using a fluorometric plasmin substrate. In the 1251-fibrin plate system, however, TSP significantly inhibited the generation of plasmin activity by TPA from Plg ( Fig. 6 ) with an Io of -60 nM. This inhibition was calcium dependent, being maximal at physiological levels of 1.5 to 2.0 mM.
Kinetic studies of Plg activation on fibrin are complicated since fibrin is both a substrate for the end product of the reaction, plasmin, and a strong positive effector of the reaction (27 Harpel, manuscript in preparation). The role of possible binary TSP-TPA complex formation in affecting the inhibition of plasmin generation remains to be determined. These studies support the hypothesis that TSP acting as a multifunctional regulator in focal areas of active hemostasis and thrombosis could serve as a prothrombotic influence, leading to increased deposition of fibrin. We have previously shown that the interaction of TSP with fibrinogen on the activated platelet surface is an important step in the platelet aggregation process (15) and have recently shown that TSP specifically complexes with HRGP (17), a plasma and platelet a-granule protein with high affinity for heparin (18) . This interaction may be important in concentrating the heparinneutralizing action of HRGP to the vicinity of a platelet plug. The findings in the present study raise the possibility that by modulating the activation of Plg by TPA, TSP could further enhance fibrin deposition at platelet-blood vessel wall interfaces. It remains to be shown how the interaction of Plg with HRGP (19) affects these interactions.
The full biological significance of the TSP-Plg interaction remains an important subject for future studies. In addition to removal of fibrin from the vascular bed, the Plg activatorplasmin system is important in other physiological and patho-logical processes (30) , such as inflammation (33) , neoplasia (34) , and embryogenesis (35, 36, 37) . Through a complex system of controls including the level of tissue production of TPA (38) , localized degradation and inactivation of TPA (39, 40) , inactivation of plasmin by circulating inhibitors (21) , and microenvironmental influences on the kinetics of Plg activation, Plg activation may be a general mechanism for generating localized proteolysis in a microenvironment (30) . TSP may play an important role in such non-fibrin mediated Plg activator systems. Although it circulates at very low levels, TSP may be present in significant concentrations in the microenvironment where Plg activation occurs, e.g., by platelet degranulation, as can occur at sites of inflammation or tumor cell metastasis, as part of the normal connective tissue or endothelial extracellular matrix or in association with cellular surfaces. Since TSP is functionally immobilized (like fibrin), it may modulate the kinetics of TPA-induced plasminogen activation at extravascular sites.
